about
Biomaterials and host versus graft response: a short reviewRole of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in ChildrenA new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseSinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Late cardiovascular complications after hematopoietic cell transplantation.Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantationPlacental lesions associated with acute atherosis.Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants.Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome.Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host diseaseCardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic trainingInfluence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantationPathophysiology of GvHD and Other HSCT-Related Major Complications.Progress and prospects: graft-versus-host disease.Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated With Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase.Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD.Clinical significance of anti-endothelial cell antibody in allogeneic hematopoietic stem cell transplantation recipients with graft-versus-host disease.Time-related arterial changes after allogeneic hematopoietic stem cell transplantation in children.Endothelial microparticles carrying hedgehog-interacting protein induce continuous endothelial damage in the pathogenesis of acute graft-versus-host disease.Endothelial damage is aggravated in acute GvHD and could predict its development.Thrombotic thrombocytopenic purpuraPost-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study
P2860
Q26764759-CD7EC407-3687-4CAE-8E86-57390E351772Q26798470-73D872DD-4FC0-43C5-81F2-E8E65583D31AQ26992169-5A18AA8C-1F18-4BE3-AC08-A3A8A3CF7694Q28076264-25A929FA-0470-4AA9-AAD9-B5E16C8A63D9Q28083417-EB66B547-1617-4700-99CD-1FA8A5FBD3E5Q33391308-B76F3020-E404-47CC-AD61-37121C71C8BEQ33605306-8D1E83AD-8A9F-44EE-AE30-0601EB9F14C8Q34138063-5258B29B-F65E-4349-9400-319209D799FCQ34288406-7D74C374-A717-4A51-9296-1F0C29F4DA47Q34390721-14107981-4F8E-4F76-A32A-A6756F7C17D5Q35558666-409B5980-40C4-429C-A901-D3DA75D9F774Q36279223-EDF4D491-749C-417A-9347-F768D52A4CD9Q36280069-3F9066B0-6566-4CA4-8466-AF9146C2E9DCQ36366581-EE49FE2D-1255-44B2-A2E3-4078BC71815EQ37213203-0E3D8BAE-8ECA-4347-8070-B72671EBDDD6Q37460433-1E4E2895-CEAC-4010-B650-E6E6352E305AQ37710572-495C82BB-AA48-4473-84E7-309FF2A37596Q37761297-37C3234C-27E4-44AE-8401-F4AFDCF2F491Q39119051-B1F7EE52-70A6-42BC-BB47-C0CC45D9B302Q41685216-31A10D9D-D1B7-4053-B699-8E81A26F32A8Q43283502-C2650E82-5ACA-40BE-9923-F37421CAEBC8Q44322030-9FFF0ADE-0949-45EA-A251-D8B807FA81D6Q46299526-4C2D83AC-AD1F-4D26-B96C-95031A4A74F8Q46574551-633B3F39-52CA-47E9-950B-B776EDB01BFAQ48222811-7B9F759E-48F5-4D7B-B43A-434DC45058ACQ57379903-46049B38-512B-445B-AFB5-C45E42890E40Q57917425-23C0384C-23D9-41FD-8207-6DD629B84ECC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vascular endothelium and graft-versus-host disease.
@en
Vascular endothelium and graft-versus-host disease.
@nl
type
label
Vascular endothelium and graft-versus-host disease.
@en
Vascular endothelium and graft-versus-host disease.
@nl
prefLabel
Vascular endothelium and graft-versus-host disease.
@en
Vascular endothelium and graft-versus-host disease.
@nl
P1476
Vascular endothelium and graft-versus-host disease.
@en
P2093
Barbara C Biedermann
P304
P356
10.1016/J.BEHA.2008.02.003
P577
2008-06-01T00:00:00Z